← Leaderboards
Jennifer Jean Lentz
Lsu Health Sciences Center
$1,506,418
Attributed
$3,659,054
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,659,054 · 2
By mechanism
R01$3,659,054 · 2
Top collaborators
- Robert Koenekoop5 shared
- Gwenaelle S Geleoc3 shared
- Wu Zhou3 shared
Most similar at Lsu Health Sciences Center
Same institution · by research overlap
- Wu Zhou$7,597,386
- Robert Koenekoop$860,199
- Katelyn N Robillard$148,508
- Jason Dongjoon Kim$48,755
Others in their field
Other Emerging Leaders on “Genetic”
- Leonard Freedman · Leidos Biomedical Research, Inc.$89,060,933
- Ted Ross · University Of Georgia$68,763,143
- Scott Topper · Broad Institute, Inc.$64,989,588
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Dale Sandler · Social And Scientific Systems, Inc.$43,209,852
Research focus
GeneticInterestFirst-In-HumanGenesHair CellsHearing ImpairmentCohortEquilibriumFutureGene Replacement TherapyDrug CandidateEffective TherapyHearingDeafnessAffectBlindnessCanadaDoseAntisense Oligonucleotide TherapyClinical TrialsGene ReplacementClinicCommunicationKnock-In Mouse
Grant awards (8)
Vestibular dysfunction and the development of therapies for Usher syndrome$635,126
R01 · FY2025 · DC · contact PI
Vestibular dysfunction and the development of therapies for Usher syndrome$638,418
R01 · FY2024 · DC · contact PI
Vestibular dysfunction and the development of therapies for Usher syndrome$665,113
R01 · FY2023 · DC · contact PI
Antisense therapy for the treatment of visual loss in Usher syndrome$345,880
R01 · FY2023 · EY · contact PI
Antisense therapy for the treatment of visual loss in Usher syndrome$335,504
R01 · FY2022 · EY · contact PI
Antisense therapy for the treatment of visual loss in Usher syndrome$335,503
R01 · FY2021 · EY · contact PI
Antisense therapy for the treatment of visual loss in Usher syndrome$345,880
R01 · FY2020 · EY · contact PI
Antisense therapy for the treatment of visual loss in Usher syndrome$357,630
R01 · FY2019 · EY · contact PI